TCL Archive Opdivo Study Shows 41 Percent One-Year Survival In Patients With at Least Two Past Therapies November 28, 2014
TCL Archive NCI Would Add Money For Centers If Number Go Up, Greenwald Says; Five Options For Changes Listed April 27, 1984
TCL Archive Genitope Therapy In Phase III Trials For Low-Grade B-Cell Non-Hodgkin’s. October 26, 2001